| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael Detmar | Q64867609 |
| P2093 | author name string | Reto Huggenberger | |
| P2860 | cites work | Evidence of IL-18 as a novel angiogenic mediator | Q24291472 |
| Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 | Q24291630 | ||
| Proteolytic processing regulates receptor specificity and activity of VEGF-C. | Q24532314 | ||
| A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes | Q24681916 | ||
| The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors | Q24685887 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice | Q28504776 | ||
| RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted anti-atherosclerotic therapy | Q28566764 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Molecular regulation of angiogenesis and lymphangiogenesis | Q29616150 | ||
| Rapid leukocyte migration by integrin-independent flowing and squeezing | Q29620345 | ||
| Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates | Q30090232 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum | Q31109080 | ||
| Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators | Q33547431 | ||
| Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis | Q33606922 | ||
| VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis | Q33615188 | ||
| The role of endothelial cell apoptosis in the effect of etanercept in psoriasis | Q33633318 | ||
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. | Q33731734 | ||
| Interleukin 1 is an autocrine regulator of human endothelial cell growth | Q33757605 | ||
| Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages | Q34091556 | ||
| Structure, function, and molecular control of the skin lymphatic system | Q34124338 | ||
| Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation | Q34161479 | ||
| Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo | Q34333796 | ||
| The chemokine receptor D6 limits the inflammatory response in vivo | Q34400531 | ||
| The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells | Q34420400 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
| An important role of lymphatic vessel activation in limiting acute inflammation | Q34997755 | ||
| Analysis of the role of chemokines in angiogenesis. | Q35048828 | ||
| Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo. | Q35215426 | ||
| Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function | Q35607278 | ||
| Dual role of tumor necrosis factor-alpha in angiogenesis | Q35830630 | ||
| Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. | Q51734752 | ||
| Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis. | Q52030313 | ||
| Ultraviolet radiation and immunology: something new under the sun--presidential address. | Q53468448 | ||
| Interleukin-2 promotes angiogenesis by activation of Akt and increase of ROS. | Q53547913 | ||
| Histopathology of rosacea. | Q53692964 | ||
| Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. | Q54658697 | ||
| Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival | Q57706454 | ||
| Cytokine profiles during infliximab monotherapy in psoriatic arthritis | Q59154943 | ||
| Interleukin-15 Promotes Angiogenesisin Vivo | Q60194035 | ||
| Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway | Q61623437 | ||
| TNF-α and IL-8 Are Upregulated in the Epidermis of Normal Human Skin after UVB Exposure: Correlation with Neutrophil Accumulation and E-Selectin Expression | Q63859627 | ||
| In Vivo Angiogenic Activity of Interleukins | Q67656351 | ||
| Inhibition of angiogenesis by vitamin D3 analogues | Q67657266 | ||
| Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis | Q69088374 | ||
| Epidermal changes in human skin following irradiation with either UVB or UVA | Q69695599 | ||
| The treatment of photoaged human skin by topical tretinoin | Q69696359 | ||
| Correlation of the vasoconstriction assay and clinical activity in psoriasis | Q69881328 | ||
| Electron Microscopic Studies of the Microcirculation in Psoriasis | Q70408965 | ||
| Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis | Q71616411 | ||
| Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo | Q72673615 | ||
| Interleukin-18 acts as an angiogenesis and tumor suppressor | Q73263318 | ||
| Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis | Q73666845 | ||
| VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation | Q73697862 | ||
| [Nerval factors in the pathomechanism of psoriasis] | Q73957463 | ||
| Angiogenesis in rheumatoid arthritis | Q74443495 | ||
| Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma | Q74453396 | ||
| Molecular regulation of UVB-induced cutaneous angiogenesis | Q77519518 | ||
| Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage | Q78024617 | ||
| A critical role of placental growth factor in the induction of inflammation and edema formation | Q78409892 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| The capillary responses in psoriatic skin | Q79080378 | ||
| Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints | Q80442904 | ||
| CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions | Q80444912 | ||
| Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage | Q81023307 | ||
| Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis | Q81177683 | ||
| Lymphangiogenesis and angiogenesis in non-phymatous rosacea | Q81322493 | ||
| An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation | Q82519880 | ||
| Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis | Q82588722 | ||
| Interleukin-20 promotes angiogenesis in a direct and indirect manner | Q82703038 | ||
| Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma | Q82781364 | ||
| Lymphangiogenesis and cancer metastasis | Q84190566 | ||
| Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. | Q40827632 | ||
| Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans | Q40831320 | ||
| Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
| Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes | Q41168770 | ||
| The codependence of angiogenesis and chronic inflammation | Q41508311 | ||
| Interleukin-8. A corneal factor that induces neovascularization | Q42050315 | ||
| Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels | Q42146832 | ||
| Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study | Q42461787 | ||
| Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate | Q42490593 | ||
| Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2--deficient mice | Q43847729 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis | Q44286057 | ||
| UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response. | Q45047267 | ||
| Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis | Q45859481 | ||
| TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis | Q46519096 | ||
| Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis | Q46926357 | ||
| Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis | Q47391889 | ||
| Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis | Q47596519 | ||
| Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis | Q47596762 | ||
| Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor | Q47663012 | ||
| Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia | Q47726749 | ||
| Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme | Q49168241 | ||
| Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression. | Q51038419 | ||
| Reduction of lymphatic vessels in photodamaged human skin | Q36098591 | ||
| Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. | Q36229454 | ||
| Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. | Q36363315 | ||
| Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis | Q36363657 | ||
| Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2 | Q36369190 | ||
| Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis | Q36371903 | ||
| VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis | Q36403416 | ||
| Increased lymphangiogenesis in joints of mice with inflammatory arthritis | Q36465469 | ||
| Angiogenesis as a therapeutic target in arthritis: lessons from oncology | Q36536359 | ||
| Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms | Q36726069 | ||
| Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor | Q36734939 | ||
| Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues | Q36803301 | ||
| Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis | Q36855744 | ||
| Angiogenesis in skin aging and photoaging | Q36922299 | ||
| Evolving functions of endothelial cells in inflammation | Q36950913 | ||
| Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro | Q36968176 | ||
| Molecular biology and pathology of lymphangiogenesis | Q37014851 | ||
| Atopic dermatitis in 2008. | Q37156230 | ||
| Mechanisms and consequences of dendritic cell migration | Q37272221 | ||
| The molecular pathology of rosacea | Q37349837 | ||
| Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells | Q37357812 | ||
| Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis | Q37379687 | ||
| Airway vascular reactivity and vascularisation in human chronic airway disease. | Q37466968 | ||
| Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis | Q37482178 | ||
| Overview of pathogenesis of systemic sclerosis | Q37504301 | ||
| Angiogenesis drives psoriasis pathogenesis | Q37534974 | ||
| Angiogenesis in asthma | Q37677829 | ||
| Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies? | Q37739648 | ||
| Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways | Q38511815 | ||
| Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states | Q38668772 | ||
| Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. | Q39758196 | ||
| Perspectives and Problems in Cutaneous Gerontology | Q39885492 | ||
| Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism | Q39984665 | ||
| IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression | Q40410750 | ||
| Differential effects of photoaging vs intrinsic aging on the vascularization of human skin | Q40621199 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammation | Q101991 |
| dermatitis | Q229256 | ||
| integumentary system | Q483213 | ||
| P304 | page(s) | 24-32 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | The journal of investigative dermatology. Symposium proceedings | Q26842290 |
| P1476 | title | The cutaneous vascular system in chronic skin inflammation | |
| P478 | volume | 15 |
| Q89718590 | A biofabricated vascularized skin model of atopic dermatitis for preclinical studies |
| Q35862114 | Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema |
| Q35862102 | Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea. |
| Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
| Q92173195 | An important role of cutaneous lymphatic vessels in coordinating and promoting anagen hair follicle growth |
| Q35138679 | An important role of the SDF-1/CXCR4 axis in chronic skin inflammation |
| Q34990214 | Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms |
| Q37739969 | Anti-inflammatory activity of niosomes entrapped with Plai oil (Zingiber cassumunar Roxb.) by therapeutic ultrasound in a rat model |
| Q38874520 | Anti-inflammatory properties of low and high doxycycline doses: an in vitro study |
| Q36991412 | Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. |
| Q34305121 | Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans |
| Q46276685 | Current insights into the pathophysiology of rosacea |
| Q38769721 | DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C. |
| Q36325038 | Dermasence refining gel modulates pathogenetic factors of rosacea in vitro |
| Q38232251 | Endoplasmic reticulum stress: key promoter of rosacea pathogenesis |
| Q26749294 | Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis |
| Q41330230 | Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis. |
| Q64079668 | Impact of Human Dermal Microvascular Endothelial Cells on Primary Dermal Fibroblasts in Response to Inflammatory Stress |
| Q38632525 | Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab |
| Q28077479 | Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features |
| Q35020075 | In vivo blood flow imaging of inflammatory human skin induced by tape stripping using optical microangiography |
| Q36233191 | In vivo label-free lymphangiography of cutaneous lymphatic vessels in human burn scars using optical coherence tomography. |
| Q53092319 | Increased blood flow and vasculature in solar lentigo. |
| Q42977967 | Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency |
| Q38266605 | Inflammation and the blood microvascular system |
| Q94468292 | Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses |
| Q26822766 | Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition |
| Q27304915 | Lymphatic vascular response to acute inflammation |
| Q41388747 | Mechanisms of CXCR7 induction in malignant melanoma development |
| Q38033656 | News on microenvironmental physioxia to revisit skin cell targeting approaches |
| Q35394537 | Presence of lymphatics in a rat tendon lesion model. |
| Q26775965 | Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation |
| Q53519437 | Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea. |
| Q50097253 | Response of the Endothelium to the Epicutaneous Application of Leukotriene B4. |
| Q33574053 | Role of vascular networks in extending glucose sensor function: Impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo |
| Q64137688 | Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines |
| Q38637734 | Short and long gap peripheral nerve repair with magnesium metal filaments. |
| Q41363933 | Skin response to epicutaneous application of anticoagulant rodenticide warfarin is characterized by differential time- and dose-dependent changes in cell activity |
| Q55083172 | Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography. |
| Q90050404 | The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases |
| Q41244028 | Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency |
| Q40814371 | Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells |
| Q37306962 | Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis |
Search more.